From Cannabis Clinics to Bitcoin Billions: KindlyMD (NAKA) Stock’s Wild 2025 Ride
Market Analysis & Forecast: For now, analysts and investors appear in “wait and see” mode. Near-term catalysts will be pivotal. These include the finalization of the Antalpha $250M convertible deal – which would inject capital but on what terms? – and the company’s next earnings report. If Bitcoin’s price continues to climb in late 2025, it could boost KindlyMD’s asset value and perhaps its stock; conversely, a crypto downturn or interest rate spike could hurt both the value of its BTC and its ability to raise funds cheaply. Price forecasts vary widely: some Wall Street firms see NAKA recovering to a few dollars, while rating agencies like Weiss effectively warn it could go lower. Given the speculative nature of this stock, extreme swings are likely to persist.